Figure 4From: Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysisPercentage of clinical responders* during the study. *Clinical responders = participants who achieved ≥ 30% reduction in ADHD-RS-IV total scores from baseline and CGI-I scores of 1 or 2.Back to article page